Stockscreener 앱 받기
2.99
1.64%
-0.05
시간 외 거래:
2.97
-0.02
-0.67%
전일 마감가:
$3.04
열려 있는:
$3.13
하루 거래량:
1.38M
Relative Volume:
1.34
시가총액:
$266.68M
수익:
$361.07M
순이익/손실:
$-71.54M
주가수익비율:
-3.7848
EPS:
-0.79
순현금흐름:
$-47.97M
1주 성능:
+6.79%
1개월 성능:
+54.12%
6개월 성능:
+1,561%
1년 성능:
+344.15%
1일 변동 폭
$2.80
$3.1459
1주일 범위
$2.26
$3.33
52주 변동 폭
$0.1253
$3.50
Oncology Institute Inc Stock (TOI) Company Profile
명칭
Oncology Institute Inc
전화
562-735-3226
주소
18000 STUDEBAKER RD, CERRITOS
TOI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TOI
Oncology Institute Inc
|
2.99 | 245.73M | 361.07M | -71.54M | -47.97M | -0.79 |
|
HCA
Hca Healthcare Inc
|
387.52 | 85.09B | 71.59B | 5.78B | 4.95B | 22.49 |
|
THC
Tenet Healthcare Corp
|
165.47 | 13.82B | 20.52B | 1.46B | 1.41B | 15.12 |
|
EHC
Encompass Health Corp
|
120.87 | 11.73B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
197.94 | 11.71B | 16.08B | 1.20B | 1.06B | 17.82 |
|
DVA
Davita Inc
|
145.41 | 10.86B | 12.82B | 936.34M | 1.47B | 10.74 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-15 | 개시 | BTIG Research | Buy |
| 2024-02-26 | 재개 | Jefferies | Buy |
| 2022-09-14 | 개시 | Guggenheim | Buy |
| 2022-08-15 | 개시 | Jefferies | Buy |
Oncology Institute Inc 주식(TOI)의 최신 뉴스
BTIG Research Begins Coverage on Oncology Institute (NASDAQ:TOI) - Defense World
The Oncology Institute, Inc. (NASDAQ:TOI) Q1 2025 Earnings Call Transcript - Insider Monkey
BTIG Initiates Coverage on Oncology Institute (TOI) with Enthusi - GuruFocus
Oncology Institute’s Earnings Call: Strong Start to 2025 - TipRanks
Oncology Institute Narrows Q1 Loss, Reaffirms 2025 Outlook On Capitation And Pharmacy Growth - Nasdaq
BTIG sets $7 price target on The Oncology Institute stock By Investing.com - Investing.com Nigeria
BTIG Initiates Oncology Institute at Buy With $7 Price Target - marketscreener.com
BTIG Initiates Coverage on Oncology Institute (TOI) with Enthusiastic Outlook | TOI Stock News - GuruFocus
The Oncology Institute’s Strong Q1 2025 Performance - TipRanks
Earnings call transcript: Oncology Institute Q1 2025 results show revenue growth By Investing.com - Investing.com South Africa
The Oncology Institute (TOI) Reports Q1 Earnings and Revenue Inc - GuruFocus
Earnings call transcript: Oncology Institute Q1 2025 results show revenue growth - Investing.com Australia
Oncology Institute Q1 2025 Earnings Call Transcript - MarketBeat
The Oncology Institute, Inc. Reports Strong Q1 2025 Financial Results and Strategic Growth Initiatives - Nasdaq
The Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical Officer - The Manila Times
The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year ... - Bluefield Daily Telegraph
The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance - GlobeNewswire
The Oncology Institute Taps Former Cigna National Oncology Director to Scale Value-Based Care Model - Stock Titan
The Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional Investor Conference - The Manila Times
The Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional ... - Eagle-Tribune
Leading Value-Based Oncology Group TOI Executives to Share Growth Strategy at B. Riley Conference - Stock Titan
Oncology Institute reports annual meeting outcomes By Investing.com - Investing.com Nigeria
The Oncology Institute to Present at Upcoming ASCO Annual - GlobeNewswire
Oncology Institute Holds Annual Stockholders Meeting - TipRanks
Oncology Institute reports annual meeting outcomes - Investing.com
Oncology Institute (TOI) Highlights Benefits of High-Value Cance - GuruFocus
Oncology Institute (TOI) Highlights Benefits of High-Value Cancer Care Model | TOI Stock News - GuruFocus
The Oncology Institute to Present at Upcoming ASCO Annual Meeting on High-Value Cancer Care Model Outcomes Showing Cost Savings and Lower Hospitalization Rates - marketscreener.com
Renaissance Technologies LLC Grows Position in The Oncology Institute, Inc. (NASDAQ:TOI) - Defense World
Oncology Institute COO Jeremy Castle Resigns - TipRanks
The Oncology Institute: Insiders Buy Up Big While Valuations Are Murky (NASDAQ:TOI) - Seeking Alpha
The Oncology Institute, Inc.'s (NASDAQ:TOI) largest shareholders are retail investors with 40% ownership, private equity firms own 24% - Yahoo Finance
The Oncology Institute, Inc. (NASDAQ:TOI) Shares Sold by Geode Capital Management LLC - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
New Outlook On Oncology Institute Inc - Stocksregister
Oncology Institute Inc [TOI] Records 50-Day SMA of $1.38 - knoxdaily.com
A new trading data show Oncology Institute Inc (TOI) is showing positive returns. - Sete News
Closing Strong: Oncology Institute Inc (TOI) Ends at 2.50, Down -14.09 from Last Close - DWinneX
Why The Oncology Institute, Inc. (TOI) is Surging in 2025 - Insider Monkey
Oncology Institute Inc Inc. (TOI) Price Performance: A Comparative Analysis with Competitors - investchronicle.com
Oncology Institute Inc (TOI)’s highs and lows: A closer look at its stock price fluctuations - uspostnews.com
Jefferies gives a Buy recommendation for Oncology Institute Inc (TOI) - knoxdaily.com
Oncology Institute Inc [TOI] Records 50-Day SMA of $1.19 - knoxdaily.com
Take off with Oncology Institute Inc (TOI): Get ready for trading - Sete News
Major Blood Cancer Center Joins CERo's Novel AML Treatment Trial, June Dosing Planned - Stock Titan
Stock Performance Spotlight: Oncology Institute Inc (TOI) Ends the Day at 2.88, Up by 6.27 - DWinneX
Oncology Institute (NASDAQ:TOI) Stock Price Up 6.3% – Still a Buy? - Defense World
The Oncology Institute Reports Third Quarter 2024 Financial Results - ADVFN
The Oncology Institute Announces First Quarter 2025 Earnings Release Date and Conference Call - The Manila Times
Leading US Oncology Group TOI Readies Q1 2025 Financial Results: Key Details for May 14 Earnings Call - Stock Titan
The Oncology Institute Expands Partnership with Helios Clinical Research to Enhance Access to Clinical Trials - Nasdaq
Oncology Institute Inc (TOI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Oncology Institute Inc 주식 (TOI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Podnos Yale | Chief Medical Officer |
Mar 26 '25 |
Buy |
1.04 |
9,056 |
9,434 |
79,049 |
| Pacala Mark L | Director |
Mar 26 '25 |
Buy |
1.04 |
90,562 |
94,338 |
224,971 |
| Johnson Karen Marie | Director |
Mar 26 '25 |
Buy |
1.04 |
36,224 |
37,735 |
203,409 |
| Hively Brad | Director |
Mar 26 '25 |
Buy |
1.04 |
9,056 |
9,434 |
675,809 |
| Castle Jeremy | Chief Operating Officer |
Mar 26 '25 |
Buy |
1.04 |
9,056 |
9,434 |
90,386 |
| Carter Robert Ross | Chief Financial Officer |
Mar 26 '25 |
Buy |
1.04 |
9,056 |
9,434 |
39,407 |
| BARASCH RICHARD A | Director |
Mar 26 '25 |
Buy |
1.04 |
1,358,448 |
1,415,095 |
1,775,641 |
| Hively Brad | Director |
Nov 26 '24 |
Buy |
0.17 |
250,000 |
42,500 |
616,753 |
| Hively Brad | Director |
Dec 02 '24 |
Buy |
0.15 |
50,000 |
7,500 |
666,753 |
0.96%
자본화:
|
볼륨(24시간):